Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer.

about

Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer.

Item

http://www.wikidata.org/entity/Q54336161

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Comparison of nodal metastasis ...... n carriers with breast cancer.

@en

Comparison of nodal metastasis ...... n carriers with breast cancer.

@nl

type

Item

label

Comparison of nodal metastasis ...... n carriers with breast cancer.

@en

Comparison of nodal metastasis ...... n carriers with breast cancer.

@nl

prefLabel

Comparison of nodal metastasis ...... n carriers with breast cancer.

@en

Comparison of nodal metastasis ...... n carriers with breast cancer.

@nl

P1476

Comparison of nodal metastasis ...... on carriers with breast cancer

@en

P2093

Alison K Bonk

http://www.w3.org/2001/XMLSchema#string

Armando E Giuliano

http://www.w3.org/2001/XMLSchema#string

Farin Amersi

http://www.w3.org/2001/XMLSchema#string

James Mirocha

http://www.w3.org/2001/XMLSchema#string

Maria E Nelson

http://www.w3.org/2001/XMLSchema#string

Michael Choi

http://www.w3.org/2001/XMLSchema#string

Parisa Mirzadehgan

http://www.w3.org/2001/XMLSchema#string

Shahrbanoo F Noori

http://www.w3.org/2001/XMLSchema#string

P2860

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases.

Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls.

Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

Prognosis of BRCA-associated breast cancer: a summary of evidence.

Pathology of hereditary breast cancer.

Breast-conserving therapy for triple-negative breast cancer.

P2888

s10434-014-3904-2

P304

3324-3329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-014-3904-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Afshin Gangi

P577

2014-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001234472

http://www.w3.org/2001/XMLSchema#string

P698

25047471

http://www.w3.org/2001/XMLSchema#string